Effects of dalteparin on anti-Xa levels cannot be predicted in critically ill COVID-19 patients
European Journal of Clinical Pharmacology
; 77(SUPPL 1):10-11, 2021.
Article
in English
| Web of Science | ID: covidwho-1312257
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Experimental Studies
/
Prognostic study
Language:
English
Journal:
European Journal of Clinical Pharmacology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS